Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Demographic profile, clinicopathological spectrum, and treatment outcomes of primary central nervous system tumors: Retrospective audit from an academic neuro-oncology unit.

Gupta T, Epari S, Moiyadi A, Shetty P, Goda JS, Krishnatry R, Chinnaswamy G, Vora T, Menon H, Patil V, Sahay A, Bano N, Jalali R.

Indian J Cancer. 2017 Oct-Dec;54(4):594-600. doi: 10.4103/ijc.IJC_543_17.

PMID:
30082541
2.

Applicability of 2008 World Health Organization classification system of hematolymphoid neoplasms: Learning experiences.

Modkharkar S, Navale P, Amare PK, Chougule A, Patkar N, Tembhare P, Menon H, Sengar M, Khattry N, Banavali S, Arora B, Narula G, Laskar S, Khanna N, Muckaden MA, Rangarajan V, Agrawal A, Shet T, Epari S, Subramanian PG, Gujral S.

Indian J Pathol Microbiol. 2018 Jan-Mar;61(1):58-65. doi: 10.4103/IJPM.IJPM_56_17.

3.

Story of survival in anaplastic large cell lymphoma - sometimes more than the anaplastic lymphoma kinase status: An evaluation of pathologic prognostic factors in 102 cases.

Agrawal K, Shet T, Sridhar E, Dhende S, Sengar M, Arora B, Laskar S, Gujral S, Menon H, Banavali S.

Indian J Pathol Microbiol. 2017 Oct-Dec;60(4):533-540. doi: 10.4103/IJPM.IJPM_778_15.

4.

Achieving scale rapidly in public health: Applying business management principles to scale up an HIV prevention program in India.

Sgaier SK, Ramakrishnan A, Wadhwani A, Bhalla A, Menon H, Baer J, Alexander A.

Healthc (Amst). 2017 Sep 21. pii: S2213-0764(16)30223-8. doi: 10.1016/j.hjdsi.2017.09.002. [Epub ahead of print]

5.

Non-adherence to CML therapy and its clinical implications in India.

Menon H.

Natl Med J India. 2017 May-Jun;30(3):142-147. Review.

PMID:
28936999
6.

A Randomized, Placebo-Controlled, Phase 1b/2 Study of Rilotumumab or Ganitumab in Combination With Platinum-Based Chemotherapy as First-Line Treatment for Extensive-Stage Small-Cell Lung Cancer.

Glisson B, Besse B, Dols MC, Dubey S, Schupp M, Jain R, Jiang Y, Menon H, Nackaerts K, Orlov S, Paz-Ares L, Ramlau R, Tang R, Zhang Y, Zhu M.

Clin Lung Cancer. 2017 Nov;18(6):615-625.e8. doi: 10.1016/j.cllc.2017.05.007. Epub 2017 May 10.

PMID:
28601388
7.

Observation on frequency & clinico-pathological significance of various cytogenetic risk groups in multiple myeloma: an experience from India.

Kadam Amare PS, Jain H, Nikalje S, Sengar M, Menon H, Inamdar N, Subramanian PG, Gujral S, Shet T, Epari S, Nair R.

Indian J Med Res. 2016 Oct;144(4):536-543. doi: 10.4103/0971-5916.200890.

8.

Immunogenetics of chronic lymphocytic leukemia.

Patkar N, Rabade N, Kadam PA, Mishra F, Muranjan A, Tembhare P, Chaudhary S, Joshi S, Jain H, Dangi U, Bagal B, Khattry N, Menon H, Gujral S, Sengar M, Subramanian PG.

Indian J Pathol Microbiol. 2017 Jan-Mar;60(1):38-42. doi: 10.4103/0377-4929.200051.

9.

Consensus in the Management of Multiple Myeloma in India at Myeloma State of the Art 2016 Conference.

Yanamandra U, Khattry N, Kumar S, Raje N, Jain A, Jagannath S, Menon H, Kumar L, Varma N, Varma S, Saikia T, Malhotra P; for IMAGe Group.

Indian J Hematol Blood Transfus. 2017 Mar;33(1):15-21. doi: 10.1007/s12288-016-0773-9. Epub 2017 Jan 2. Review.

10.

Outcomes of Short Segment Posterior Instrumentation in Unstable Thoracolumbar Fractures.

Gajjar SH, Menon HJ, Chaudhari N, Chaudhari V.

J Clin Diagn Res. 2016 Nov;10(11):RC04-RC08. doi: 10.7860/JCDR/2016/23133.8825. Epub 2016 Nov 1.

11.

Population pharmacokinetics of Reditux™, a biosimilar Rituximab, in diffuse large B-cell lymphoma.

Gota V, Karanam A, Rath S, Yadav A, Tembhare P, Subramanian P, Sengar M, Nair R, Menon H.

Cancer Chemother Pharmacol. 2016 Aug;78(2):353-9. doi: 10.1007/s00280-016-3083-x. Epub 2016 Jun 21.

PMID:
27329361
12.

Characteristics of BCR-ABL kinase domain mutations in chronic myeloid leukemia from India: not just missense mutations but insertions and deletions are also associated with TKI resistance.

Patkar N, Ghodke K, Joshi S, Chaudhary S, Mascerhenas R, Dusseja S, Mahadik S, Gaware S, Tembhare P, Gujral S, Kabre S, Kadam-Amare P, Jain H, Dangi U, Bagal B, Khattry N, Sengar M, Arora B, Narula G, Banavali S, Menon H, Subramanian PG.

Leuk Lymphoma. 2016 Nov;57(11):2653-60. doi: 10.3109/10428194.2016.1157868. Epub 2016 Mar 21.

PMID:
26999421
13.

Mediastinal Gray Zone Lymphoma: A Wider Category Than We Think?

Verma A, Shet T, Epari S, Gupta M, Gujral S, Khanna N, Laskar S, Sengar M, Arora B, Menon H, Banavali S.

Int J Surg Pathol. 2016 Aug;24(5):382-93. doi: 10.1177/1066896916635816. Epub 2016 Mar 7.

PMID:
26957476
14.

ISCHEMIRs: Finding a Way Through the Obstructed Cerebral Arteries.

Nampoothiri SS, Menon HV, Das D, Krishnamurthy RG.

Curr Drug Targets. 2016;17(7):800-10. Review.

PMID:
25981603
15.

A retrospective study of correlation of morphologic patterns, MIB1 proliferation index, and survival analysis in 134 cases of plasmacytoma.

Ghodke K, Shet T, Epari S, Sengar M, Menon H, Gujral S.

Ann Diagn Pathol. 2015 Jun;19(3):117-23. doi: 10.1016/j.anndiagpath.2015.02.006. Epub 2015 Mar 5.

PMID:
25842207
16.

Myeloproliferative neoplasms working group consensus recommendations for diagnosis and management of primary myelofibrosis, polycythemia vera, and essential thrombocythemia.

Agarwal MB, Malhotra H, Chakrabarti P, Varma N, Mathews V, Bhattacharyya J, Seth T, Gayathri K, Menon H, Subramanian PG, Sharma A, Bhattacharyya M, Mehta J, Vaid AK, Shah S, Aggarwal S, Gogoi PK, Nair R, Agarwal U, Varma S, Prasad SV, Manipadam MT.

Indian J Med Paediatr Oncol. 2015 Jan-Mar;36(1):3-16. doi: 10.4103/0971-5851.151770.

17.

Treatment results in advanced stage Hodgkin's lymphoma: a retrospective study.

Jain H, Sengar M, Nair R, Menon H, Laskar S, Shet T, Gujral S, Sridhar E.

J Postgrad Med. 2015 Apr-Jun;61(2):88-91. doi: 10.4103/0022-3859.150446.

18.

Syntaxin1A-mediated Resistance and Hypersensitivity to Isoflurane in Drosophila melanogaster.

Zalucki OH, Menon H, Kottler B, Faville R, Day R, Bademosi AT, Lavidis N, Karunanithi S, van Swinderen B.

Anesthesiology. 2015 May;122(5):1060-74. doi: 10.1097/ALN.0000000000000629.

PMID:
25738637
19.

A simplified scoring system to document variant patterns in nodular lymphocyte predominant Hodgkin lymphoma.

Shet T, Panjwani P, Epari S, Sengar M, Prasad M, Arora B, Laskar S, Gujral S, Menon H, Banavali S.

Leuk Lymphoma. 2015 Jun;56(6):1651-8. doi: 10.3109/10428194.2014.961013. Epub 2014 Nov 20.

PMID:
25248885
20.

MYD88 mutant lymphoplasmacytic lymphoma/Waldenström macroglobulinemia has distinct clinical and pathological features as compared to its mutation negative counterpart.

Patkar N, Subramanian PG, Deshpande P, Ghodke K, Tembhare P, Mascarenhas R, Muranjan A, Chaudhary S, Bagal B, Gujral S, Sengar M, Menon H.

Leuk Lymphoma. 2015 Feb;56(2):420-5. doi: 10.3109/10428194.2014.924123. Epub 2014 Aug 4.

PMID:
24828863
21.

Dengue fever as a cause of febrile neutropenia in adult acute lymphoblastic leukemia: a single center experience.

Jain H, Sengar M, Menon H, Dangi U, Biswas S, Chandrakanth MV.

Hematol Oncol Stem Cell Ther. 2014 Sep;7(3):125-6. doi: 10.1016/j.hemonc.2014.04.002. Epub 2014 Apr 30. No abstract available.

22.

Blastic plasmacytoid dendritic cell neoplasm: a rare subtype of myeloid leukemia.

Jain H, Sengar M, Menon H, Chandrakanth MV.

Hematol Oncol Stem Cell Ther. 2014 Jun;7(2):97-8. doi: 10.1016/j.hemonc.2014.03.003. Epub 2014 Apr 29. No abstract available.

23.

Bone marrow involvement in nodular lymphocyte predominant Hodgkin lymphoma occurs in tumors with a variant pattern.

Panjwani P, Epari S, Sengar M, Laskar S, Menon H, Shet T.

Leuk Lymphoma. 2015 Jan;56(1):236-8. doi: 10.3109/10428194.2014.916802. Epub 2014 Jun 27. No abstract available.

PMID:
24766468
24.

Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors.

Kim SH, Menon H, Jootar S, Saikia T, Kwak JY, Sohn SK, Park JS, Jeong SH, Kim HJ, Kim YK, Oh SJ, Kim H, Zang DY, Chung JS, Shin HJ, Do YR, Kim JA, Kim DY, Choi CW, Park S, Park HL, Lee GY, Cho DJ, Shin JS, Kim DW.

Haematologica. 2014 Jul;99(7):1191-6. doi: 10.3324/haematol.2013.096776. Epub 2014 Apr 4.

25.

Comparison of the efficacy and safety of Rituximab (Mabthera™) and its biosimilar (Reditux™) in diffuse large B-cell lymphoma patients treated with chemo-immunotherapy: A retrospective analysis.

Roy PS, John S, Karankal S, Kannan S, Pawaskar P, Gawande J, Bagal B, Khattry N, Sengar M, Menon H, Gujral S, Nair R.

Indian J Med Paediatr Oncol. 2013 Oct;34(4):292-8. doi: 10.4103/0971-5851.125248.

26.

Extranodal natural killer/T cell lymphomas with extranasal disease in non-endemic regions are disseminated or have nasal primary: a study of 84 cases from India.

Shet T, Suryawanshi P, Epari S, Sengar M, Rangarajan V, Menon H, Laskar S.

Leuk Lymphoma. 2014 Dec;55(12):2748-53. doi: 10.3109/10428194.2014.894188. Epub 2014 Apr 3.

PMID:
24597982
27.

Therapeutic drug monitoring for imatinib: Current status and Indian experience.

Arora B, Gota V, Menon H, Sengar M, Nair R, Patial P, Banavali SD.

Indian J Med Paediatr Oncol. 2013 Jul;34(3):224-8. doi: 10.4103/0971-5851.123752.

28.

Issues in current management of chronic myeloid leukemia: Importance of molecular monitoring on long term outcome.

Menon H.

South Asian J Cancer. 2013 Jan;2(1):38-43. doi: 10.4103/2278-330X.105893. Review.

29.

Nodular lymphocyte predominant Hodgkin lymphoma and diphenylhydantoin: report of a case and review of the literature.

Sharma S, Menon H, Sengar M, Gujral S.

Indian J Pathol Microbiol. 2013 Oct-Dec;56(4):440-2. doi: 10.4103/0377-4929.125364. Review.

30.

Radiation therapy for early stage unfavorable Hodgkin lymphoma: is dose reduction feasible?

Laskar S, Kumar DP, Khanna N, Menon H, Sengar M, Arora B, Gujral S, Shet T, Sridhar E, Rangarajan V, Muckaden MA, Nair R, Banavali S.

Leuk Lymphoma. 2014 Oct;55(10):2356-61. doi: 10.3109/10428194.2013.871631. Epub 2014 Mar 7.

PMID:
24354681
31.

Sunitinib in metastatic renal cell carcimoma: a single-center experience.

Krishna VM, Noronha V, Prabhash K, Joshi A, Patil V, Bhosale B, Ravi T, Menon H, Gupta S, Banavali SD, Bakshi G, Tangaonkar HB.

Indian J Cancer. 2013 Jul-Sep;50(3):268-73. doi: 10.4103/0019-509X.118725.

32.

Temporal variation of aerosol optical depth and associated shortwave radiative forcing over a coastal site along the west coast of India.

Menon HB, Shirodkar S, Kedia S, S R, Babu S, Moorthy KK.

Sci Total Environ. 2014 Jan 15;468-469:83-92. doi: 10.1016/j.scitotenv.2013.08.013. Epub 2013 Sep 6.

PMID:
24012896
33.

Is there a role for metronomic induction (and maintenance) therapy in elderly patients with acute myeloid leukemia? A literature review.

Tandon N, Banavali S, Menon H, Gujral S, Kadam PA, Bakshi A.

Indian J Cancer. 2013 Apr-Jun;50(2):154-8. doi: 10.4103/0019-509X.117033.

34.

Prevalence and patterns of cytomegalovirus DNAemia in adult patients with acute lymphoblastic leukemia on chemotherapy.

Gulia S, Dangi U, Biswas S, Kelkar R, Menon H, Sengar M.

Leuk Lymphoma. 2014 May;55(5):1209-11. doi: 10.3109/10428194.2013.825372. Epub 2013 Aug 31. No abstract available.

PMID:
23865832
35.

Learning about scale, measurement and community mobilisation: reflections on the implementation of the Avahan HIV/AIDS initiative in India.

Wheeler T, Kiran U, Dallabetta G, Jayaram M, Chandrasekaran P, Tangri A, Menon H, Kumta S, Sgaier S, Ramakrishnan A, Moore J, Wadhwani A, Alexander A.

J Epidemiol Community Health. 2012 Oct;66 Suppl 2:ii16-25. doi: 10.1136/jech-2012-201081.

36.

A randomized comparative trial evaluating the safety and efficacy of liposomal amphotericin B (Fungisome) versus conventional amphotericin B in the empirical treatment of febrile neutropenia in India.

Jadhav MP, Shinde VM, Chandrakala S, Jijina F, Menon H, Arora B, Kurkure PA, Parikh PM, Kshirsagar NA.

Indian J Cancer. 2012 Jan-Mar;49(1):107-13. doi: 10.4103/0019-509X.98933.

37.

A retrospective audit of clinicopathological attributes and treatment outcomes of adolescent and young adult non-Hodgkin lymphomas from a tertiary care center.

Sengar M, Akhade A, Nair R, Menon H, Shet T, Gujral S, Sridhar E, Laskar S, Muckaden M.

Indian J Med Paediatr Oncol. 2011 Oct;32(4):197-203. doi: 10.4103/0971-5851.95140.

38.

Morphological spectrum of leukemic mantle cell lymphoma.

Rahman K, Subramanian PG, Kadam PA, Gadage V, Galani K, Mittal N, Ghogale S, Badrinath Y, Ansari R, Kushte S, Nair R, Sengar M, Menon H, Gujral S.

Indian J Pathol Microbiol. 2012 Jan-Mar;55(1):66-71. doi: 10.4103/0377-4929.94860.

39.

Clinico-pathological profile of Hairy cell leukemia: critical insights gained at a tertiary care cancer hospital.

Galani KS, Subramanian PG, Gadage VS, Rahman K, Ashok Kumar MS, Shinde S, Mahadik S, Ansari R, Sengar M, Menon H, Nair R, Gujral S.

Indian J Pathol Microbiol. 2012 Jan-Mar;55(1):61-5. doi: 10.4103/0377-4929.94858.

40.

Parenthood in patients with acute promyelocytic leukemia after treatment with arsenic trioxide: a case series.

Gupta S, Bagel B, Gujral S, Subramanian PG, Khattry N, Menon H, Nair R.

Leuk Lymphoma. 2012 Nov;53(11):2192-4. doi: 10.3109/10428194.2012.679936. Epub 2012 Apr 30.

PMID:
22452590
41.

Clinicopathologic study and outcome analysis of thyroid lymphomas: experience from a tertiary cancer center.

Katna R, Shet T, Sengar M, Menon H, Laskar S, Prabhash K, D'Cruz A, Nair R.

Head Neck. 2013 Feb;35(2):165-71. doi: 10.1002/hed.22928. Epub 2012 Feb 24.

PMID:
22368156
42.

Characterization of cryptic rearrangements, deletion, complex variants of PML, RARA in acute promyelocytic leukemia.

Amare PK, Baisane C, Nair R, Menon H, Banavali S, Kabre S, Gujral S, Subramaniam P.

Indian J Hum Genet. 2011 May;17(2):54-8. doi: 10.4103/0971-6866.86174.

43.

Histopathological audit of splenectomies received at a cancer hospital.

Gujral S, Lad P, Subramanian PG, Shet TM, Epari S, Laskar S, Muckaden M, Menon H, Sengar M, Nair R.

Indian J Pathol Microbiol. 2011 Jul-Sep;54(3):487-96. doi: 10.4103/0377-4929.85080.

44.

Large cell neuroendocrine carcinoma of the endometrium: an extremely uncommon diagnosis, but worth the efforts.

Deodhar KK, Kerkar RA, Suryawanshi P, Menon H, Menon S.

J Cancer Res Ther. 2011 Apr-Jun;7(2):211-3. doi: 10.4103/0973-1482.82942.

45.

A phase II, multicenter, open-label randomized study of motesanib or bevacizumab in combination with paclitaxel and carboplatin for advanced nonsquamous non-small-cell lung cancer.

Blumenschein GR Jr, Kabbinavar F, Menon H, Mok TS, Stephenson J, Beck JT, Lakshmaiah K, Reckamp K, Hei YJ, Kracht K, Sun YN, Sikorski R, Schwartzberg L; Motesanib NSCLC Phase II Study Investigators.

Ann Oncol. 2011 Sep;22(9):2057-67. doi: 10.1093/annonc/mdq731. Epub 2011 Feb 14.

PMID:
21321086
46.

Improved surgical access for facial dimple creation.

Thomas M, Menon H, D'Silva J.

Aesthet Surg J. 2010 Nov-Dec;30(6):798-801. doi: 10.1177/1090820X10383399.

PMID:
21131452
47.

Validation of recursive partitioning analysis classification in patients with brain metastases from non-small cell lung cancer treated with short-course accelerated radiotherapy.

Agarwal JP, Wadasadawala T, Munshi A, Chadda P, Apsani R, Upasani M, Laskar SG, Pramesh CS, Karimundackal G, Menon H, Prabhash K, Jambhekar N.

Clin Oncol (R Coll Radiol). 2010 Dec;22(10):837-43. doi: 10.1016/j.clon.2010.05.022. Epub 2010 Jun 29.

PMID:
20591632
48.

Lymphoma masquerading as acute leukemia-mystery unfolded.

Jain P, Prabhash K, Menon H, Gupta S, Parikh PM.

Indian J Cancer. 2010 Apr-Jun;47(2):222-3. doi: 10.4103/0019-509X.63001. No abstract available.

49.

Isolated central nervous system involvement by lymphomatoid granulomatosis in an adolescent: a case report and review of literature.

Gupta T, Wadasadawala T, Shet T, Jalali R, Menon H.

Pediatr Hematol Oncol. 2010 Mar;27(2):150-9. doi: 10.3109/08880010903536185. Review.

PMID:
20201696
50.

Low dose of Hyaluronidase to treat over correction by HA filler--a case report.

Menon H, Thomas M, D'silva J.

J Plast Reconstr Aesthet Surg. 2010 Apr;63(4):e416-7. doi: 10.1016/j.bjps.2010.01.005. Epub 2010 Feb 4. No abstract available.

PMID:
20133216

Supplemental Content

Support Center